Skip to content

Study to Evaluate the Performance of a New 2-piece Ostomy Appliance vs. Flexima® 3S in Patients With Enterostomy

Randomized Controlled Multicenter Study to Evaluate the Performance of a New 2-piece Ostomy Appliance vs. Flexima® 3S in Patients With Enterostomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03572673
Enrollment
38
Registered
2018-06-28
Start date
2018-05-08
Completion date
2019-04-30
Last updated
2018-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enterostomy

Brief summary

To compare the performance of the comparator Flexima 3S appliance to a new 2-piece appliance in patients with enterostomy.

Interventions

DEVICEFlexima 3S

Flexima 3S (2-piece appliance) with drainable pouch

DEVICENew 2-piece ostomy appliance

New 2-piece ostomy appliance with drainable pouch

Sponsors

BBraun Medical SAS
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient having a colostomy or an ileostomy for at least 1 month * patient currently using a flat appliance * patient wearing his appliance, on average, at least 5 days * patient with a stoma's diameter less than 65 mm * patient who agrees to participate in the evaluation and who have signed the inform consent * patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)

Exclusion criteria

* Patient currently suffering from peristomal skin complications (bleeding or red and broken skin at the time of inclusion) * Patient receiving or having received, within the last month, chemotherapy or corticotherapy * Patient already participating in another clinical study or who have previously participated in this investigation * Pregnant or breast-feeding woman

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in base plate wear time, on average every 5 days, up to 21 (±3) days, for each study periodOn average every 5 days, up to 21 (±3) days for each periodFor each base plate, the wear time will be evaluated during 21 (±3) days

Secondary

MeasureTime frameDescription
Assessment of the main reason of base plate removalFrom date of randomization, on average every 5 days, after each base plate removal, up to 21 (±3) days for each study periodAfter each base plate removal, the patient will describe on a 7-point scale the main reason of base plate removal (habit, hygiene, leakage under the base plate, unsticking of the base plate periphery, unsticking of the base plate, not only on the periphery, ask for the study but the base plate could stay longer in place, other, to specify. No value is considered as the better outcome, it's only descriptive value.
Assessment of acceptabilityAt the end of each study period (21 (±3) days), at visit 2 (21 (±3) days) and at visit 3 (42 (±6) days)At the end of each study period (21 (±3) days), the patient will assess on a 4-point scale each parameter of acceptability (very good, good, bad, very bad. The very good value is considered as the better outcome.
Assessment of the condition of peristomal skinAfter base plate removal at protocol visit 1 (day 0) and visit 2 (at 21 (±3) days)Using a standardized measuring ostomy skin tool
Preference between Flexima® 3S and the new 2-piece ostomy applianceAt the end of the study, at 42 (±6) daysAt the end of the study, the patient will notify the preference between Flexima® 3S and the new 2-piece appliance
Safety: Adverse(s) Event(s)From date of randomization until the date of first adverse event, assessed up to 42 (±6) daysDescription of all adverse event related or not to the devices studied
Assessment of use of accessoriesFrom date of randomization, on average every 5 days, after each base plate removal, up to 21 (±3) days for each study periodAfter each base plate removal, the patient will describe on a 8-point scale the use of accessories (none, protective spray, powder, paste, ring, adhesive remover, belt, other, to specify. No value is considered as the better outcome, it's only descriptive value.

Countries

Malaysia

Contacts

Primary ContactAude Michaud
aude.michaud@bbraun.com+33632542788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026